Finerenone: A Novel Drug Discovery for the Treatment of Chronic Kidney Disease.

Published in: Current drug discovery technologies (2024)

The present review covers the complete picture of ADME properties, bioanalytical techniques, clinical trials, toxicity, and possible avenues in this arena. Finerenone is effective compared to other mineralocorticoid receptor-like spironolactone and eplerenone, for the treatment of chronic kidney disease.

Keyphrases

chronic kidney disease
drug discovery
clinical trial
end stage renal disease
combination therapy
replacement therapy
study protocol